Skip to main content
Clinical Trials/NCT03823963
NCT03823963UnknownPhase 4

A Monocentric, Comparative and Randomized Study on Pressure Ulcers Prevention With Mepilex® Border Sacrum Dressing in Scheduled Cardiovascular Surgery

University Hospital, Clermont-Ferrand2 sites in 1 country478 target enrollmentStarted: December 10, 2018Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 4
Sponsor
Enrollment
478
Locations
2
Primary Endpoint
Pressure ulcer incidence

Study Overview

Brief Summary

The study is a randomised controlled trial of patients admitted for a scheduled cardiac surgery at the Clermont-Ferrand hospital.

Patients meeting the study inclusion criteria will be allocated to either the control group that will receive pressure ulcer prevention standard care or the intervention group that will receive pressure ulcer prevention standard care plus have a Mepilex® Border dressing applied to their sacrum.

Detailed Description

The main objective of this research is to evaluate the impact of Mepilex Border® dressing applied in addition to standard pressure ulcer prevention protocol, in a French hospital setting, in at-risk patients in a cardiovascular surgery unit with full hospitalisation including block operation and ICU.

Hypothesis

Patients treated with Mepilex® Border dressings will have a lower incidence rate of sacral pressure ulcer development than patients receiving standard care.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Subject over 18 years of age,
  • Subject programmed to benefit from cardiac surgery with sternotomy,
  • Subject capable and willing to comply with the protocol and willing to give his written consent,
  • Subject affiliated to a social security system

Exclusion Criteria

  • Subject with a skin lesion in the sacral area upon admission,
  • Subject admitted for emergency cardiovascular surgery (unscheduled subject),
  • Subject admitted for heart transplant surgery,
  • Subject participating in another clinical study or in a period of exclusion from a study previous,
  • Subject with a linguistic or psychological disability to sign informed consent,
  • Subject refusing to give written consent,
  • Subject deprived of liberty by administrative or judicial decision, under guardianship or curatorship.

Arms & Interventions

Standard care

Other

pressure ulcer prevention standard care

Intervention: Standard care (Other)

standard care + Mepilex® Border

Experimental

pressure ulcer prevention standard care + Mepilex® Border applied on sacrum

Intervention: Mepilex® Border dressing (Combination Product)

standard care + Mepilex® Border

Experimental

pressure ulcer prevention standard care + Mepilex® Border applied on sacrum

Intervention: Standard care (Other)

Outcomes

Primary Outcomes

Pressure ulcer incidence

Time Frame: 0-20 days

Incidence of sacral pressure ulcers acquired during patients' hospital stay

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
University Hospital, Clermont-Ferrand
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials